Outsourcing-Pharma.com Newsletter

Ipsen to take writedown after Lonza warning letter hits supply

Ipsen may take a writedown up to €180m after FDA action against its API CMO, Lonza, created supply uncertainties... Read

Almac challenges "one-size-fits-all" DNA analysis with new custom-fit service

Almac says its first leap into Next Generation Sequencing (NGS) data analysis services is a much needed-change from the industry's current "one-size-fits-all" offering... Read

Marken forms tech team as cold chain market heats up

Trial logistics firm Marken says new expert development team will create 'industry changing,' cold chain technologies... Read

CMO news roundup – Foster, Excella, Catalent and RohnerChem

A round-up of news in the contract manufacturing space, with developments at Foster Delivery Sciences, Excella, Catalent and RohnerChem... Read

People on the move

Outsourcing-Pharma presents its weekly round-up of the latest career changes within the pharmaceutical industry, including news from Icon, AbelsonTaylor and Chiltern... Read

News in brief

Clinart MENA rebrands to meet demand for Middle East trials

Clinart MENA has hired a new CEO and rebranded to benefit from rising interest in conducting trials in the Middle East... Read

GLOBAL INDUSTRY NEWS

AstraZeneca to cut 1,350 'operations support' jobs

AstraZeneca will cut 1,350 operations jobs in the next few years as part of wide ranging restructuring move... Read

EU plan to add APIs to pollutant watch list could raise costs

European Commission plans to add three APIs to its list of water polluting chemicals could result in costs to pharmaceutical companies... Read

FDA calls for more powers to adopt nationwide ePedigree

The US FDA has called for more authority to ensure any track-and-trace system is binding for industry and pre-empts state laws... Read

Big pharma shifting trial focus to US at expense of Asia; Parexel

Strategic clients increasingly want to outsource trials to the 'old world' of the US and Europe at the expense of Asia, Parexel said... Read

CMO Cytovance adds 1,000L bioreactor for trial supplies

Cytovance Biologics has added a 1,000L bioreactor at its Oklahoma site to support scale-up as clients move through clinical trials... Read

Encap lands long-term manufacturing contract

Encap Drug Delivery has won a contract manufacturing deal for a European licensed liquid-filled capsule product after the owner parted from its current CMO... Read

Absorption Systems sees potential in ocular testing services

Preclinical CRO Absorption Systems is adding new technologies and capabilities for the analysis of ocular drugs at its lab in San Diego, US... Read

Avoca invites CROs to join Pharma sponsors in Quality management debate

Sponsors want CROs to join the debate on quality management in clinical research says the Avoca Group, which has invited contractors to sign up to its recently established industry consortium... Read

News in brief

Lpath suspends dosing after FDA warns of CMO failings

Lpath has suspending dosing in its iSONEP clinical trials after learning the CMO handling fill and finish has cGMP failings... Read